Early and middle term results after surgical treatment for slipped capital femoral epiphysis

Sun, Wei; Li, Zirong; Shi, Zhencai; Yang, Yurun; Wang, Bailiang; Guo, Wanshou; Liu, Zhaohui

doi:10.1111/j.1757-7861.2010.00120.x

Cited by 7 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patient-reported HRQoL and hip-specific outcome (SF-36 and WOMAC questionnaires) did not reveal any signs of hip symptoms or functional compromise. These findings are consistent with the literature, in which symptomatic joint degeneration resulting from cam-type deformity normally does not develop until the fifth decade of life ( Stulberg et al 1975 , Boyer et al 1981 , Beck et al 2005 , Wei et al 2011 , Wensaas et al 2011 , 2012 ). However, Zilkens et al (2011) found decreased SF-36 scores but only for the subscale parameters of physical function and role physical.…”

Section: Discussionsupporting

confidence: 92%

Cam deformity and hip degeneration are common after fixation of a slipped capital femoral epiphysis

Klit¹,

Gosvig

Magnussen

et al. 2014

Acta Orthopaedica

View full text Add to dashboard Cite

Background and purpose —Slipped capital femoral epiphysis is thought to result in cam deformity and femoroacetabular impingement. We examined: (1) cam-type deformity, (2) labral degeneration, chondrolabral damage, and osteoarthritic development, and (3) the clinical and patient-reported outcome after fixation of slipped capital femoral epiphysis (SCFE).Methods —We identified 28 patients who were treated with fixation of SCFE from 1991 to 1998. 17 patients with 24 affected hips were willing to participate and were evaluated 10–17 years postoperatively. Median age at surgery was 12 (10–14) years. Clinical examination, WOMAC, SF-36 measuring physical and mental function, a structured interview, radiography, and MRI examination were conducted at follow-up.Results —Median preoperative Southwick angle was 22o (IQR: 12–27). Follow-up radiographs showed cam deformity in 14 of the 24 affected hips and a Tönnis grade > 1 in 1 affected hip. MRI showed pathological alpha angles in 15 affected hips, labral degeneration in 13, and chondrolabral damage in 4. Median SF-36 physical score was 54 (IQR: 49–56) and median mental score was 56 (IQR: 54–58). These scores were comparable to those of a Danish population-based cohort of similar age and sex distribution.Median WOMAC score was 100 (IQR: 84–100).Interpretation —In 17 patients (24 affected hips), we found signs of cam deformity in 18 hips and early stages of joint degeneration in 10 hips. Our observations support the emerging consensus that SCFE is a precursor of cam deformity, FAI, and joint degeneration. Neither clinical examination nor SF-36 or WOMAC scores indicated physical compromise.

show abstract

Section: Discussionsupporting

confidence: 92%

Cam deformity and hip degeneration are common after fixation of a slipped capital femoral epiphysis

Klit¹,

Gosvig

Magnussen

et al. 2014

Acta Orthopaedica

View full text Add to dashboard Cite

show abstract

“…Slipped Capital Femoral Epiphysis (SCFE) is considered the most common hip disorder affecting adolescents. [1][2][3][4] It is a Salter-Harris type I fracture characterized by slippage through the hypertrophic zone of the upper femoral epiphysis in a backward direction. [5][6][7][8] The aetiology remains controversial but generally multifactorial in origin; implicating genetic, constitutional and endocrine factors.…”

Section: Introductionmentioning

confidence: 99%

Total hip arthroplasty in patients with slipped capital femoral epiphysis: a systematic analysis of 915 cases

Kenanidis¹,

Kakoulidis²,

Panagiotidou³

et al. 2021

Orthop Rev (Pavia)

View full text Add to dashboard Cite

There is limited evidence on the outcomes of Total Hip Arthroplasty (THA) in Slipped Capital Femoral Epiphysis (SCFE) patients. This systematic review aims to evaluate the current literature in terms of survival rate, functional outcomes, complications and types of implants of THA in SCFE patients. Following the established methodology of PRISMA guidelines, PubMed, Cochrane library, ScienceDirect and Ovid MEDLINE were systematically searched from inception to September 2018. The search criteria used were: (“total hip arthroplasty’’ OR ‘’total hip replacement’’ OR “hip arthroplasty’’ OR ‘’hip replacement’’) AND (‘’slipped capital femoral epiphysis’’ OR ‘’slipped upper femoral epiphysis’’ OR ‘’femoral epiphysis’’). Ten studies were finally included in the analysis and were qualitatively appraised using the Newcastle-Ottawa tool. Variables were reported differently between studies. The sample size varied from 12 to 374 THAs. A total of 877 patients undergone 915 THAs. The mean reported follow-up ranged from 4.4 to 15.2 years and the mean patients’ age at the time of THA from 26 to 50 years. Four studies specified the type of implants used, with 62% being uncemented, 24% hybrid (uncemented cup/cemented stem) and 14% cemented. All but three studies reported the mean survival of implants that ranged from 64.9% to 94.8%. A limited number of complications were mentioned. There was a tendency for more favorable functional outcomes in modern studies. Modern THA-studies in SCFE patients showed improvement of survivorship, clinical outcomes and patient satisfaction. Future higher-quality studies are necessary to estimate long-term postoperative outcomes better.

show abstract

Common Childhood Orthopaedic Conditions, their Care and Management

Judd

2014

Orthopaedic and Trauma Nursing

View full text Add to dashboard Cite

Early and middle term results after surgical treatment for slipped capital femoral epiphysis

Cited by 7 publications

References 19 publications

Cam deformity and hip degeneration are common after fixation of a slipped capital femoral epiphysis

Cam deformity and hip degeneration are common after fixation of a slipped capital femoral epiphysis

Total hip arthroplasty in patients with slipped capital femoral epiphysis: a systematic analysis of 915 cases

Common Childhood Orthopaedic Conditions, their Care and Management

Contact Info

Product

Resources

About